Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Deoxycortone Pivalate
2. Desoxycoticosterone Trimethylacetate
3. Percoten Pivalate
1. 808-48-0
2. Deoxycortone Pivalate
3. Docp
4. Desoxycortone Pivalate
5. Dtma
6. Deoxycorticosterone Pivalate
7. 11-deoxycorticosterone Pivalate
8. Deoxycortone Trimethylacetate
9. Desoxycorticosterone Trimethylacetate
10. Deoxycorticosterone Trimethylacetate
11. 11-deoxycorticosterone, Pivalate
12. Neodin-depositum
13. Cortexone M
14. Percorten M
15. 11-deoxy Corticosterone Pivalate
16. Percorten Pivalate
17. Desoxycorticosteronepivalate
18. Chebi:50782
19. Desoxycorticosterone Pivalate (usp)
20. Desoxycorticosterone Pivalate [usp]
21. 3,20-dioxopregn-4-en-21-yl 2,2-dimethylpropanoate
22. 16665t4a2x
23. Pregn-4-ene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)-
24. [2-[(8s,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate
25. Percorten V
26. Percorten (tn)
27. Nsc 95278
28. 21-(2,2-dimethyl-1-oxopropoxy)pregn-4-ene-3,20-dione
29. Nsc-95278
30. Unii-16665t4a2x
31. 3,20-dioxopregn-4-en-21-yl Pivalate
32. Ncgc00159355-02
33. Einecs 212-366-0
34. Zycortal
35. Brn 3174879
36. Desoxycorticosterone-pivalate
37. Dsstox_cid_26036
38. Dsstox_rid_81301
39. Dsstox_gsid_46036
40. 4-08-00-02196 (beilstein Handbook Reference)
41. Schembl120007
42. Chembl1200592
43. Dtxsid8046036
44. Corticosterone, Deoxy-, Pivalate
45. Zinc4082455
46. Tox21_111599
47. Akos032428733
48. Desoxycortone Pivalate [mart.]
49. Db01134
50. Desoxycortone Pivalate [who-dd]
51. Ncgc00160511-01
52. Cas-808-48-0
53. Desoxycorticosterone Pivalate [mi]
54. Hy-107917
55. Cs-0030864
56. Desoxycorticosterone Pivalate [vandf]
57. Desoxycorticosterone Trimethyl Acetate
58. Desoxycorticosterone Pivalate [usp-rs]
59. D03699
60. 808d480
61. A839987
62. Desoxycorticosterone Pivalate [green Book]
63. Desoxycorticosterone Pivalate [orange Book]
64. Desoxycorticosterone Pivalate [usp Monograph]
65. Desoxycortone Pivalate [ema Epar Veterinary]
66. W-104224
67. Q27092729
68. [2-[(8s,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] 2,2-dimethylpropanoate
Molecular Weight | 414.6 g/mol |
---|---|
Molecular Formula | C26H38O4 |
XLogP3 | 4.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 414.27700969 g/mol |
Monoisotopic Mass | 414.27700969 g/mol |
Topological Polar Surface Area | 60.4 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 787 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Examined for treatment of adrenocortical insufficiency especially in multiple sclerosis, congenital cerebral palsy, polyarteritis nodosa, and rheumatoid arthritis. Currently only approved in treating cats and dogs for the treatment of Addison's disease.
For use as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison's disease).
Used to treat adrenocortical insufficiency, desoxycorticosterone pivalate is a mineralocorticoid hormone and an analogue of desoxycorticosterone. It primarily acts on the metabolism of sodium, potassium and water. When the drug is given, there is decreased excretion of sodium accompanied by increased excretion of potassium; the concentration of sodium in the blood is thereby increased whereas that of potassium is decreased. There is a concomitant increase in the volume of blood and extracellular fluids, with a fall in hematocrit. It increases the rate of renal tubular absorption of sodium.
QH02AA03
Desoxycorticosterone Pivalate binds to the mineralocorticoid receptor. Mineralocorticoids are a family of steroids, secreted by the adrenal cortex, necessary for the regulation of a number of metabolic processes including electrolyte regulation. Desoxycorticosterone pivalate exerts its effect through its interaction with the mineralocorticoid receptor (MR), whereby it reacts with the receptor proteins to form a steroid-receptor complex. This complex moves into the nucleus, where it binds to chromatin which results in genetic transcription of cellular DNA to messenger RNA. The steroid hormones appear to induce transcription and synthesis of specific proteins, which produce the physiological effects seen after administration.
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Desoxycorticosterone Pivalate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Desoxycorticosterone Pivalate, including repackagers and relabelers. The FDA regulates Desoxycorticosterone Pivalate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Desoxycorticosterone Pivalate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Desoxycorticosterone Pivalate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Desoxycorticosterone Pivalate supplier is an individual or a company that provides Desoxycorticosterone Pivalate active pharmaceutical ingredient (API) or Desoxycorticosterone Pivalate finished formulations upon request. The Desoxycorticosterone Pivalate suppliers may include Desoxycorticosterone Pivalate API manufacturers, exporters, distributors and traders.
click here to find a list of Desoxycorticosterone Pivalate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Desoxycorticosterone Pivalate DMF (Drug Master File) is a document detailing the whole manufacturing process of Desoxycorticosterone Pivalate active pharmaceutical ingredient (API) in detail. Different forms of Desoxycorticosterone Pivalate DMFs exist exist since differing nations have different regulations, such as Desoxycorticosterone Pivalate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Desoxycorticosterone Pivalate DMF submitted to regulatory agencies in the US is known as a USDMF. Desoxycorticosterone Pivalate USDMF includes data on Desoxycorticosterone Pivalate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Desoxycorticosterone Pivalate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Desoxycorticosterone Pivalate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Desoxycorticosterone Pivalate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Desoxycorticosterone Pivalate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Desoxycorticosterone Pivalate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Desoxycorticosterone Pivalate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Desoxycorticosterone Pivalate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Desoxycorticosterone Pivalate suppliers with NDC on PharmaCompass.
Desoxycorticosterone Pivalate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Desoxycorticosterone Pivalate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Desoxycorticosterone Pivalate GMP manufacturer or Desoxycorticosterone Pivalate GMP API supplier for your needs.
A Desoxycorticosterone Pivalate CoA (Certificate of Analysis) is a formal document that attests to Desoxycorticosterone Pivalate's compliance with Desoxycorticosterone Pivalate specifications and serves as a tool for batch-level quality control.
Desoxycorticosterone Pivalate CoA mostly includes findings from lab analyses of a specific batch. For each Desoxycorticosterone Pivalate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Desoxycorticosterone Pivalate may be tested according to a variety of international standards, such as European Pharmacopoeia (Desoxycorticosterone Pivalate EP), Desoxycorticosterone Pivalate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Desoxycorticosterone Pivalate USP).
LOOKING FOR A SUPPLIER?